Testing components | ALK
Graph-leftGraph-right
Graph-leftGraph-right
Graph-leftGraph-right

At the core of ALK, innovation thrives. We have spent the past 100+ years pioneering within the field of allergy with the continued purpose of helping more people living with allergy.

Our deep understanding of the underlying biology and how allergy works has given us the foundation to develop a range of allergy immunotherapy treatments and management options, forming the core of our current product range. We remain committed to advancing science and are dedicated to innovate and expand our Research & Development (R&D) pipeline, continuously providing novel concepts within allergy research and treatment.

Our scientific focus is centered around respiratory allergy, food allergy, anaphylaxis and adjacent diseases areas.

Are you a young scientist making significant contributions within the field of allergy research? Apply for the prestigious Henning Løwenstein Research Award 2025 now! Deadline is 15 August 2025.


Expand scientific knowledge
Enhance the understanding of allergies and the treatments through scientific insights

Increase treatment awareness
Equip healthcare providers with the tools to effectively communicate all available treatment options to patients, facilitating informed decision-making

Continuous engagement
Establish opportunities for meaningful interactions and sustained engagement among Health Care Professionals globally, before and after the event through education

Global expertise to local impact
Facilitate broader access to events and educational activities to enrich knowledge and peer-to-peer medical collaboration
30 years of advancing allergy immunotherapy
Last updated: 25.03.2025